Black Bird Biotech

Black Bird Biotech Net Margin

The Net Profit Margin of Black Bird Biotech (BBBT) as of Nov 4, 2026 is -2,301.94 %. In the previous year, Net Profit Margin was -2,009.09 % — a change of 14.58% (lower).

Net Margin

-2,301.94 %

YoY

14.58%

Last updated:

Net Profit Margin of Black Bird Biotech is 2023 -2,301.94 % . Net Profit Margin of Black Bird Biotech was 2022 -2,009.09 % . It decreases by 14.58% lower compared to the previous year.

Black Bird Biotech's net margin stands at -2,301.9%, up from -2,362.3% several years earlier.

The Black Bird Biotech Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2010
-11.96 USD
Jan 1, 2011
-0.14 USD
Jan 1, 2019
-2,362.33 USD
Jan 1, 2020
-284.06 USD
Jan 1, 2021
-1,734.00 USD
Jan 1, 2022
-2,009.09 USD
Jan 1, 2023
-2,301.94 USD
The Black Bird Biotech Net Margin history
YEARNet MarginYoY
-2,301.94 %+14.58%
-2,009.09 %+15.86%
-1,734.00 %+510.44%
-284.06 %-87.98%
-2,362.33 %+1.65 M%
-0.14 %-98.80%
-11.96 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Black Bird Biotech Stock analysis

What does Black Bird Biotech do? Black Bird Biotech, Inc. generates revenue through the manufacture and sale of cannabidiol (CBD) products under its brands MiteXstream, Grizzly Creek Naturals, and Black Bird American Hemp. The company's subsidiary Black Bird Potentials, Inc. (BB Potentials) produces CBD oils, gummies, pet treats, and personal care products under the Grizzly Creek Naturals brand. Big Sky American Dist., LLC (Big Sky American) distributes Grizzly Creek Naturals products alongside other consumer retail items in Western Montana, serving retail customers in that region. The firm's product portfolio targets consumers seeking CBD-infused wellness and personal care solutions across multiple segments. BB Potentials focuses on CBD product lines including oils, gummies, and pet treats, while Black Bird American Hemp likely caters to broader hemp-based consumer markets. Big Sky American acts as a distributor for Grizzly Creek Naturals, expanding market reach in Western Montana without direct sales to end consumers. The company's revenue streams are derived from B2B distribution agreements with Big Sky American and direct sales of its branded CBD products to end consumers through various channels. Black Bird Biotech's business model relies on a dual approach: manufacturing and branding CBD products for direct consumer sales, and partnering with Big Sky American for regional distribution. The Grizzly Creek Naturals brand is central to both direct sales and distribution, with products available in retail settings across Western Montana. The company's subsidiaries, BB Potentials and Big Sky American, facilitate production and distribution, ensuring market penetration in key geographic areas. Black Bird Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Black Bird Biotech stock

Net Profit Margin of Black Bird Biotech is -2,301.94 % in 2023.

Net Profit Margin of Black Bird Biotech changed from -2,009.09 % to -2,301.94 %, representing a 14.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Black Bird Biotech since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Black Bird Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Black Bird Biotech

All Key Metrics — Black Bird Biotech